Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis have?
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis has 274 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis published?
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis has 2017 year in the ScholarIQ index.
What is the open-access status of Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis?
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis has green oa status in the ScholarIQ index.
What is the DOI of Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis?
The DOI for Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis is on the source record.
What is the PMID of Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis?
The PMID for Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis is on the source record.
What is the OpenAlex record for Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis?
The OpenAlex for Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis is on the source record.